Dosage levels for topical application are usually between 1% and 3% GHK-Cu in skincare and haircare products
Temperature affects the kinetic energy within molecules, accelerating chemical reactions that break down peptide structures
Factors that influence results: baseline testosterone level, age, body composition, training status, sleep quality, diet, and adherence to the protocol
As other Phase I studies using D+Q in the context of AD report out, we will be positioned to begin determining whether there is a convergence of data for specific disease states (e.g., NCT04785300 and NCT05422885 are both AD Phase I trials using D+Q), or study/site-specific changes are noted
SSRIs and other antidepressants increase BDNF over time, so combining them with exogenous BDNF modulators could theoretically produce additive or unpredictable effects